"Relaxin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A water-soluble polypeptide (molecular weight approximately 8,000) extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. (Dorland, 28th ed)
| Descriptor ID |
D012065
|
| MeSH Number(s) |
D06.472.334.734.769 D06.472.699.715 D12.644.548.762
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Relaxin".
Below are MeSH descriptors whose meaning is more specific than "Relaxin".
This graph shows the total number of publications written about "Relaxin" by people in this website by year, and whether "Relaxin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2017 | 7 | 2 | 9 |
| 2018 | 4 | 0 | 4 |
| 2019 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Relaxin" by people in Profiles.
-
Effects of Serelaxin in Patients with Acute Heart Failure. N Engl J Med. 2019 08 22; 381(8):716-726.
-
Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis. Clin Exp Rheumatol. 2019 Jul-Aug; 37 Suppl 119(4):69-75.
-
The other serelaxin in acute heart failure study: lessons from a pragmatic clinical trial. Eur J Heart Fail. 2019 03; 21(3):334-336.
-
Relaxin-3 regulates corticotropin-releasing factor gene expression in cultured rat hypothalamic 4B cells. Neurosci Lett. 2019 01 23; 692:137-142.
-
The subset of patients with acute heart failure able to secrete relaxin-2 at pregnancy concentrations could have a longer survival: a pilot study. Biomarkers. 2018 Sep; 23(6):573-579.
-
Associations between serum relaxin 2, aneurysm formation/size and severity of atherosclerosis: a preliminary prospective analysis. Acta Pharmacol Sin. 2018 Jul; 39(7):1243-1248.
-
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF. Int J Cardiol. 2018 02 15; 253:91-96.
-
Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients. Clin Exp Hypertens. 2018; 40(7):637-643.
-
Evidence of altered brain regulatory gene expression in tobacco-exposed fetuses. J Perinat Med. 2017 Dec 20; 45(9):1045-1053.
-
The relationship of circulating relaxin-2 concentrations with short-term prognosis in patients with acute heart failure: the RELAHF study. Eur J Heart Fail. 2017 09; 19(9):1205-1209.